Effect of quercetin on paraoxonase 2 levels in RAW264.7 macrophages and in human monocytes - Role of quercetin metabolism

International Journal of Molecular Sciences

Volumn 10, Issue 9, 2009, Pages 4168-4177

  Boesch Saadatmandi, Christine ^a   Pospissil, Renata Toedter ^a   Graeser, Anne Christin ^a   Canali, Raffaella ^b   Boomgaarden, Inka ^a   Doering, Frank ^a   Wolffram, Siegfried ^a   Egert, Sarah ^a   Mueller, Manfred James ^a   Rimbach, Gerald ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

Author keywords

Atherosclerosis; Flavonoid; Macrophage; Paraoxonase 2; Quercetin

Indexed keywords

ARYLDIALKYLPHOSPHATASE 2; EXCIPIENT; FLAVONOID; GELATIN; ISORHAMNETIN; MANNITOL; MESSENGER RNA; PLACEBO; QUERCETIN; QUERCETIN 3 GLUCURONIDE; RNA; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; WESTERN BLOTTING;

ATHEROSCLEROSIS; FLAVONOID; MACROPHAGE; PARAOXONASE 2; QUERCETIN;

ANIMALS; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; CELL LINE; ENZYME INDUCTION; FEMALE; GENE EXPRESSION; HUMANS; MACROPHAGES; MALE; MICE; MONOCYTES; OBESITY; PILOT PROJECTS; QUERCETIN; RNA, MESSENGER;

MURINAE;

EID: 70350074991     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms10094168     Document Type: Article

References (27)

1. Horke, S.; Witte, I.; Wilgenbus, P.; Kruger, M.; Strand, D.; Forstermann, U. Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation. Circulation 2007, 115, 2055-2064. (Pubitemid 46625957)
2. Ng, C.J.; Wadleigh, D.J.; Gangopadhyay, A.; Hama, S.; Grijalva, V.R.; Navab, M.; Fogelman, A.M.; Reddy, S.T. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J. Biol. Chem. 2001, 276, 44444-44449. (Pubitemid 37391215)
3. Rosenblat, M.; Draganov, D.; Watson, C.E.; Bisgaier, C.L.; La Du, B.N.; Aviram, M. Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 468-474. (Pubitemid 36337224)
4. Aviram, M.; Rosenblat, M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic. Biol. Med. 2004, 37, 1304-1316. (Pubitemid 39349234)
5. Ng, C.J.; Bourquard, N.; Grijalva, V.; Hama, S.; Shih, D.M.; Navab, M.; Fogelman, A.M.; Lusis, A.J.; Young, S.; Reddy, S.T. Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: Anti-atherogenic role for paraoxonase-2. J. Biol. Chem. 2006, 281, 29491-29500.
6. Ng, C.J.; Hama, S.Y.; Bourquard, N.; Navab, M.; Reddy, S.T. Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein Edeficient mice. Mol. Genet. Metab. 2006, 89, 368-373.
7. Rosenblat, M.; Hayek, T.; Hussein, K.; Aviram, M. Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: Effect of atorvastatin therapy. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 175-180. (Pubitemid 38082430)
8. Fortunato, G.; Di Taranto, M.D.; Bracale, U.M.; Del Guercio, L.; Carbone, F.; Mazzaccara, C.; Morgante, A.; D'Armiento, F.P.; D'Armiento, M.; Porcellini, M.; Sacchetti, L.; Bracale, G.; Salvatore, F. Decreased paraoxonase-2 expression in human carotids during the progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 594-600.
9. Egert, S.; Wolffram, S.; Bosy-Westphal, A.; Boesch-Saadatmandi, C.; Wagner, A.E.; Frank, J.; Rimbach, G.; Mueller, M.J. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J. Nutr. 2008, 138, 1615-1621.
10. Boesch-Saadatmandi, C.; Wolffram, S.; Minihane, A.M.; Rimbach, G. Effect of apoE genotype and dietary quercetin on blood lipids and TNF-alpha levels in apoE3 and apoE4 targeted gene replacement mice. Br. J. Nutr. 2009, 101, 1440-1443.
11. Erdman, J.W., Jr.; Balentine, D.; Arab, L.; Beecher, G.; Dwyer, J.T.; Folts, J.; Harnly, J.; Hollman, P.; Keen, C.L.; Mazza, G.; Messina, M.; Scalbert, A.; Vita, J.; Williamson, G.; Burrowes, J. Flavonoids and heart health: Proceedings of the ILSI north America flavonoids workshop, May 31-June 1, 2005, Washington, DC. J. Nutr. 2007, 137, 718S-737S.
12. Gouedard, C.; Barouki, R.; Morel, Y. Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol. Cell. Biol. 2004, 24, 5209-5222. (Pubitemid 38738157)
13. Shiner, M.; Fuhrman, B.; Aviram, M. Macrophage paraoxonase 2 (PON2) expression is upregulated by pomegranate juice phenolic anti-oxidants via PPAR gamma and AP-1 pathway activation. Atherosclerosis 2007, 195, 313-321. (Pubitemid 350087961)
14. Shiner, M.; Fuhrman, B.; Aviram, M. Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages. Free Radic. Biol. Med. 2004, 37, 2052-2063. (Pubitemid 39491324)
15. Romero, M.; Jimenez, R.; Sanchez, M.; Lopez-Sepulveda, R.; Zarzuelo, M.J.; O'Valle, F.; Zarzuelo, A.; Perez-Vizcaino, F.; Duarte, J. Quercetin inhibits vascular superoxide production induced by endothelin-1: Role of NADPH oxidase, uncoupled eNOS and PKC. Atherosclerosis 2009, 202, 58-67.
16. Lim, J.A.; Kim, S.H. Transcriptional activation of an anti-oxidant mouse Pon2 gene by dexamethasone. BMB Rep. 2009, 42, 421-426.
17. Egert, S.; Bosy-Westphal, A.; Seiberl, J.; Kurbitz, C.; Settler, U.; Plachta-Danielzik, S.; Wagner, A.E.; Frank, J.; Schrezenmeir, J.; Rimbach, G.; Wolffram, S.; Muller, M.J. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: A double-blinded, placebo-controlled cross-over study. Br. J. Nutr. 2009, doi:10.1017/S0007114509359127.
18. O'Leary, K.A.; Day, A.J.; Needs, P.W.; Sly, W.S.; O'Brien, N.M.; Williamson, G. Flavonoid glucuronides are substrates for human liver beta-glucuronidase. FEBS Lett. 2001, 503, 103-106. (Pubitemid 32769964)
19. Murota, K.; Terao, J. Antioxidative flavonoid quercetin: Implication of its intestinal absorption and metabolism. Arch Biochem. Biophys. 2003, 417, 12-17. (Pubitemid 36960043)
20. Day, A.J.; Mellon, F.; Barron, D.; Sarrazin, G.; Morgan, M.R.; Williamson, G. Human metabolism of dietary flavonoids: Identification of plasma metabolites of quercetin. Free Radic. Res. 2001, 35, 941-952. (Pubitemid 34065683)
21. Mullen, W.; Graf, B.A.; Caldwell, S.T.; Hartley, R.C.; Duthie, G.G.; Edwards, C.A.; Lean, M.E.; Crozier, A. Determination of flavonol metabolites in plasma and tissues of rats by HPLCradiocounting and tandem mass spectrometry following oral ingestion of [2-(14)C]quercetin-4′- glucoside. J. Agric. Food Chem. 2002, 50, 6902-6909. (Pubitemid 35253191)
22. Manach, C.; Morand, C.; Texier, O.; Favier, M.L.; Agullo, G.; Demigne, C.; Regerat, F.; Remesy, C. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J. Nutr. 1995, 125, 1911-1922.
23. Sesink, A.L.; O'Leary, K.A.; Hollman, P.C. Quercetin glucuronides but not glucosides are present in human plasma after consumption of quercetin-3-glucoside or quercetin-4′-glucoside. J. Nutr. 2001, 131, 1938-1941.
24. Rimbach, G.; Weinberg, P.D.; de Pascual-Teresa, S.; Alonso, M.G.; Ewins, B.A.; Turner, R.; Minihane, A.M.; Botting, N.; Fairley, B.; Matsugo, S.; Uchida, Y.; Cassidy, A. Sulfation of genistein alters its antioxidant properties and its effect on platelet aggregation and monocyte and endothelial function. Biochim. Biophys. Acta 2004, 1670, 229-237. (Pubitemid 38229773)
25. Turner, R.; Baron, T.; Wolffram, S.; Minihane, A.M.; Cassidy, A.; Rimbach, G.; Weinberg, P.D. Effect of circulating forms of soy isoflavones on the oxidation of low density lipoprotein. Free Radic. Res. 2004, 38, 209-216. (Pubitemid 38181178)
26. Borenfreund, E.; Puerner, J.A. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol. Lett. 1985, 24, 119-124.
27. Klapper, M.; Dopner, M.; Vock, C.; Nitz, I.; Helwig, U.; Schrezenmeir, J.; Doring, F. Expression analysis of genes involved in fat assimilation in human monocytes. IUBMB Life 2006, 58, 435-440. (Pubitemid 43995629)